ISO 9001:2015 Certified
Live Customer Support
4.5/5 on Trustpilot
100% Quality Guarantee

Spesolimab Biosimilar - Anti-IL-36R Antibody - Low endotoxin, Azide free (A323749)

Recombinant humanized monoclonal antibody to IL-36R for ELISA, FACS, Kinetics (BLI), Kinetics (SPR) and Functional Assay.

Shipping Information

$40
Dispatched from St. Louis, MO.
Lead Time: 12-18 business days.
Name
Spesolimab Biosimilar - Anti-IL-36R Antibody - Low endotoxin, Azide free
Description
Recombinant humanized monoclonal antibody to IL-36R.
Applications
ELISA, FACS, Kinetics (BLI), Kinetics (SPR), Functional Assay
Reactivity
Human
Host
Humanized
Clonality
Monoclonal
Isotype
IgG
Light Chains
kappa
Conjugate

Unconjugated

Purification
Protein A affinity chromatography.
Concentration
Reconstitution dependent.
Molecular Weight
This antibody has a predicted MW of 145.5 kDa.
Purity
> 90% (by SDS-PAGE and SEC-HPLC).
Product Form
Lyophilized
Reconstitution
Reconstitute with 100µl of sterile double-distilled water to bring antibody to 1mg/ml concentration. Gently shake to solubilize completely. Do not vortex!
Formulation
Lyophilized from 25mM Histadine, pH 6.2, with 8% Sucrose and 0.01% Tween80.
Storage
Shipped at 4°C. Lyophilized: Store at -20°C to -80°C. Reconstituted: Aliquot and store at -80°C. Product is stable for one year. Avoid freeze/thaw cycles.
Synonyms
IL-1Rrp2, IL-36 receptor, IL1R-rp2, IL1RRP2, Interleukin-1 receptor-like 2, Interleukin-1 receptor-related protein 2
Disclaimer
This product is for research use only. It is not intended for diagnostic or therapeutic use.
Publishing research using Spesolimab Biosimilar - Anti-IL-36R Antibody - Low endotoxin, Azide free (A323749)? Please let us know so that we can list the citation on this page.

Alternative products to Spesolimab Biosimilar - Anti-IL-36R Antibody - Low endotoxin, Azide free (A323749)

Proteins predicted to interact with IL1RL2

Predicted protein interactions based upon String database. Revelancy score correlates with probability of interaction.
99.9% Relevancy Score
99.9% Relevancy Score
99.5% Relevancy Score
99.1% Relevancy Score
98% Relevancy Score
96.6% Relevancy Score
88.5% Relevancy Score
87.5% Relevancy Score
82.6% Relevancy Score